Unraveling the Abbreviated Development Path

Publication of the Public Consultation for the review of RDC 200 - what is new?

NEW REGULATORY FRAMEWORK OF API

What are the new expectations for the development of incremental products and medicines?

INCREMENTAL INNOVATION: How to prepare for the changes that will come with the revision of RDC 200

Why are 24% of drug registrations still rejected?

Cannabis: challenges and opportunities

NEW API REGULATORY FRAMEWORK: Will ANVISA and international manufacturers be prepared?

What is important about the new regulatory framework for good manufacturing practices?